Abstract:Background and Objectives: Impulse control disorders (ICDs) are characterized by potentially harmful actions resulting from disturbances in the self-control of emotions and behavior. ICDs include disorders such as gambling, hypersexuality, binge eating, and compulsive buying. ICDs are known non-motor symptoms in Parkinson's disease (PD) and are associated primarily with the use of dopaminergic treatment (DRT) and especially dopamine agonists (DA). However, in atypical parkinsonism (APS), such as progressive supranuclear palsy (PSP) or multiple system atrophy (MSA), there are only single case reports of ICDs without attempts to determine the risk factors for their occurrence. Moreover, numerous reports in the literature indicate increased impulsivity in PSP. Our study aimed to determine the frequency of individual ICDs in APS compared to PD and identify potential factors for developing ICDs in APS. Materials and Methods: Our prospective study included 185 patients with PD and 35 with APS (27 patients with PSP and 9 with MSA) hospitalized between 2020 and 2023 at the Neurological Department of University Central Hospital in Katowice. Each patient was examined using the Questionnaire for Impulsive–Compulsive Disorders in Parkinson's Disease (QUIP) to assess ICDs. Additionally, other scales were used to assess the advancement of the disease, the severity of depression, and cognitive impairment. Information on age, gender, age of onset, disease duration, and treatment used were collected from medical records and patient interviews. Results: ICDs were detected in 23.39% of patients with PD (including binge eating in 11.54%, compulsive buying in 10.44%, hypersexuality in 8.79%, and pathological gambling in 4.40%), in one patient with MSA (hypersexuality and pathological gambling), and in 18.52% of patients with PSP (binge eating in 3.70%, compulsive buying in 7.41%, and hypersexuality in 11.11%). We found no differences in the frequency of ICDs between individual diseases (p = 0.4696). We confirmed that the use of higher doses of DA and L-dopa in patients with PD, as well as a longer disease duration and the presence of motor complications, were associated with a higher incidence of ICDs. However, we did not find any treatment effect on the incidence of ICDs in APS. Conclusions: ICDs are common and occur with a similar frequency in PD and APS. Well-described risk factors for ICDs in PD, such as the use of DRT or longer disease duration, are not fully reflected in the risk factors for ICDs in APS. This applies especially to PSP, which, unlike PD and MSA, is a tauopathy in which, in addition to the use of DRT, other mechanisms related to the disease, such as disorders in neuronal loops and neurotransmitter deficits, may influence the development of ICDs. Further prospective multicenter studies recruiting larger groups of patients are needed to fully determine the risk factors and mechanisms of ICD development in APS.

Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study

Recent Perspectives on Impulse Control Disorder in Dopamine Agonist-Treated Patients in Endocrine Practice

Impulse control disorders in hyperprolactinemic patients on dopamine agonist therapy

Impulse control disorders and use of dopamine agonists in early onset Parkinson's disease

Risk Factors of Impulsive-Compulsive Behaviors in PD Patients: a Meta-Analysis

Advances in magnetic resonance imaging of impulsive-compulsive behavior in Parkinson′s disease

Concomitant Othello Syndrome and Impulse Control Disorders in a Patient with Parkinson’s Disease: A Case Report

Research progress of Pakinson disease with impulse control disorder

Validation of the Chinese Version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease

Impulse Control Disorders in Parkinson's Disease: An Overview of Risk Factors, Pathogenesis and Pharmacological Management

Impulse control disorders in Parkinson’s disease: a national Swedish registry study on high-risk treatments and vulnerable patient groups

Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs

Morphometric alterations of the mesocorticolimbic network in Parkinson's disease with impulse control disorders

Dopaminergic therapy disrupts decision‐making in impulsive‐compulsive Parkinsonian patients

Impulse Control Disorders in Parkinson's Disease and Atypical Parkinsonian Syndromes—Is There a Difference?

Subjective feelings associated with expectations and rewards during risky decision-making in impulse control disorder

Impulse control disorders in Parkinson's disease are associated with dysfunction in stimulus valuation but not action valuation

Impulse control disorder: Review on clinical, pharmacologic, and genetic risk factors

Impulse control behaviours in patients with Parkinson's disease after subthalamic deep brain stimulation: de novo cases and 3-year follow-up

Study on Pharmacological Treatment of Impulse Control Disorders in Parkinson's Disease

New pharmacological and neuromodulation approaches for impulsive-compulsive behaviors in Parkinson's disease